ALXN

Alexion Pharmaceuticals Inc

ALXN

Overview Fund Activity

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

Healthcare Drug Manufacturers - General

Financial journalist opinion

JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion

HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with Alexion.

JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion

5 Biotech Acquisition Targets To Accumulate In 2024

Valuations in the biotech market have fallen, making it a good time for acquisitions in the industry. Investors should focus on commercial-stage biotech companies that generate revenue, as they provide a safety net in uncertain economic conditions.

JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology

HYOGO, Japan--(BUSINESS WIRE)--JCR announced an agreement with Alexion for the development of novel oligonucleotide therapeutics to support targeted delivery using J-Brain Cargo®.

JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology

See News Rankings

Charts implemented using Lightweight Charts™